1. Home
  2. FRAF vs ACRS Comparison

FRAF vs ACRS Comparison

Compare FRAF & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Financial Services Corporation

FRAF

Franklin Financial Services Corporation

HOLD

Current Price

$49.07

Market Cap

229.0M

Sector

Finance

ML Signal

HOLD

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$3.54

Market Cap

311.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRAF
ACRS
Founded
1906
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.0M
311.0M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
FRAF
ACRS
Price
$49.07
$3.54
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.75
AVG Volume (30 Days)
16.8K
2.3M
Earning Date
01-01-0001
05-27-2026
Dividend Yield
2.67%
N/A
EPS Growth
N/A
69.01
EPS
3.39
N/A
Revenue
N/A
$1,683,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.53
$1.05
52 Week High
$57.51
$4.89

Technical Indicators

Market Signals
Indicator
FRAF
ACRS
Relative Strength Index (RSI) 42.68 55.72
Support Level $47.25 $2.76
Resistance Level $53.59 $3.78
Average True Range (ATR) 1.67 0.23
MACD -0.30 0.05
Stochastic Oscillator 29.69 76.26

Price Performance

Historical Comparison
FRAF
ACRS

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: